Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance

Diabetes

Volumn 58, Issue 11, 2009, Pages 2498-2505

  Deng, Zhong Bin ^a   Poliakov, Anton ^b   Hardy, Robert W ^c   Clements, Ronald ^d   Liu, Cunren ^a   Liu, Yuelong ^a   Wang, Jianhua ^a   Xiang, Xiaoyu ^a   Zhang, Shuangqin ^a   Zhuang, Xiaoying ^a   Shah, Spandan V ^a   Sun, Dongmei ^a   Michalek, Sue ^e   Grizzle, William E ^c   Garvey, Timothy ^d   Mobley, Jim ^b   Zhang, Huang Ge ^a,f  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

^f BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; EXOSOME; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; CELL COMMUNICATION; CELL DIFFERENTIATION; EXOSOMES; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MICROSCOPY, ELECTRON; MONOCYTES; RECOMBINANT PROTEINS; RETINOL-BINDING PROTEINS, PLASMA; TOLL-LIKE RECEPTOR 4;

EID: 70350542786     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0216     Document Type: Article

References (45)

1. Nakamachi T, Nomiyama T, Gizard F, et al. PPARα agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 2007;56:1662-1670
2. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124 (Pubitemid 43121796)
3. Varma V, Yao-Borengasser A, Rasouli N, et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 2007;92:666-672
4. Liang CP, Han S, Okamoto H, et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2004;113:764-773
5. Morrison CD, Huypens P, Stewart LK, et al. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity. Biochim Biophys Acta 2008;1792:409-416
6. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830
7. Arkan MC, Hevener AL, Greten FR, et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198
8. Cawthorn WP, Sethi JK. TNF-α and adipocyte biology. FEBS Lett 2008; 582:117-131
9. De Taeye BM, Novitskaya T, McGuinness OP, et al. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 2007;293:E713-E725 (Pubitemid 47358983)
10. Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 2008;9:20-29 (Pubitemid 350264626)
11. Klover PJ, Clementi AH, Mooney RA. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005;146:3417-3427
12. Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007;292:E166-E174
13. Kim F, Pham M, Luttrell I, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007;100:1589-1596 (Pubitemid 46897262)
14. Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-3025 (Pubitemid 44684486)
15. Song MJ, Kim KH, Yoon JM, et al. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006;346:739-745
16. Suganami T, Mieda T, Itoh M, et al. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007;354:45-49 (Pubitemid 46123196)
17. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986-1998 (Pubitemid 47195825)
18. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362 (Pubitemid 41065039)
19. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563 (Pubitemid 43882351)
20. Haider DG, Schindler K, Prager G, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007;92:1168-1171 (Pubitemid 46465698)
21. Looze C, Yui D, Leung L, et al. Proteomic profiling of human plasma exosomes identifies PPARγ as an exosome-associated protein. Biochem Biophys Res Commun 2009;378:433-438
22. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-659 (Pubitemid 47214727)
23. Xiang X, Poliakov A, Liu C, et al. Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer 2009;124:2621-2633
24. Liu C, Yu S, Zinn K, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006;176:1375-1385 (Pubitemid 43134279)
25. Wang GJ, Liu Y, Qin A, et al. Thymus exosomes-like particles induce regulatory T cells. J Immunol 2008;181:5242-5248
26. Yu S, Liu C, Su K, et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007;178:6867-6875 (Pubitemid 46847412)
27. Li L, Hsu HC, Grizzle WE, et al. Cellular mechanism of thymic involution. Scand J Immunol 2003;57:410-422
28. Ruan H, Pownall HJ. Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase- α enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes 2001;50:233-240
29. Aoki N, Jin-no S, Nakagawa Y, et al. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 2007;148:3850-3862
30. Lancaster GI, Febbraio MA. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem 2005;280:23349-23355
31. Escola JM, Kleijmeer MJ, Stoorvogel W, et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998;273:20121-20127 (Pubitemid 28377568)
32. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004;101:13368-13373 (Pubitemid 39209672)
33. Skokos D, Botros HG, Demeure C, et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003;170:3037-3045 (Pubitemid 36302178)
34. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166:7309-7318 (Pubitemid 32525606)
35. Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003;278:10963-10972 (Pubitemid 36792644)
36. Yuen DY, Dwyer RM, Matthews VB, et al. Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-α expression. Diabetes 2009;58:1086-1095
37. Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997;389:610-614
38. Hofmann C, Lorenz K, Braithwaite SS, et al. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994;134:264-270
39. Biswas SK, Bist P, Dhillon MK, et al. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 2007;179:4083-4092
40. Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem 2008;283:3988-3996
41. Kagan JC, Su T, Horng T, et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 2008;9:361-368
42. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003;301:640-643 (Pubitemid 36927946)
43. Cusson-Hermance N, Khurana S, Lee TH, et al. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{κ}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005;280:36560-36566 (Pubitemid 41587731)
44. Jeyaseelan S, Young SK, Fessler MB, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J Immunol 2007;178:3153-3160 (Pubitemid 46333197)
45. Suzuki M, Sugimoto Y, Ohsaki Y, et al. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. J Neurosci 2007;27:1879-1891